Share Price and Basic Stock Data
Last Updated: February 10, 2026, 9:54 pm
| PEG Ratio | 56.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Andrew Yule & Company Ltd operates in the Plantations sector, focusing primarily on tea and coffee. The company’s market capitalization stood at ₹1,052 Cr, with a share price of ₹21.5. Over the past few quarters, revenue trends have shown volatility. Sales reported in September 2022 were ₹116.07 Cr, which peaked at ₹119.98 Cr in December 2022 but subsequently declined to ₹58.58 Cr by June 2023. The latest quarterly sales for September 2023 recovered slightly to ₹87.99 Cr. This fluctuation indicates a challenging operating environment, possibly influenced by factors such as climate conditions, production costs, and market demand. The trailing twelve months (TTM) sales figure recorded was ₹294 Cr, indicating a potential contraction compared to previous fiscal years. The annual sales for FY2024 and FY2025 are reported at ₹310 Cr and ₹311 Cr, respectively, reflecting stagnation in growth. Overall, the revenue trends suggest a need for strategic adjustments to stabilize and enhance sales performance.
Profitability and Efficiency Metrics
Profitability metrics for Andrew Yule & Company Ltd reveal significant challenges. The operating profit margin (OPM) reported a negative figure of -6.45% as of September 2023, reflecting ongoing operational inefficiencies. Furthermore, the company’s net profit for the latest quarter was merely ₹5 lakh, indicative of a profit margin that has been under pressure, with a net profit margin of -8.19% for FY2025. The interest coverage ratio stood at 0.00x, highlighting the inability to cover interest expenses, which poses a severe risk to financial stability. Over the last several quarters, the operating profit has been consistently negative, with figures plunging to -₹35.14 Cr in March 2024. Efficiency ratios also show deterioration, as return on equity (ROE) was reported at 7.96%, which is relatively low for the sector. The company’s cash conversion cycle (CCC) of -71 days suggests that it effectively manages working capital, but the underlying profitability issues overshadow this operational efficiency.
Balance Sheet Strength and Financial Ratios
Andrew Yule & Company’s balance sheet reflects a mixed picture of financial health. As of March 2025, total borrowings stood at ₹120 Cr, while reserves were recorded at ₹264 Cr. The debt-to-equity ratio of 0.31 indicates a moderate level of leverage, suggesting that the company is not excessively reliant on debt financing. However, the interest coverage ratio of 0.00x raises concerns regarding the ability to service this debt. Additionally, the current ratio is low at 0.66, signaling potential liquidity issues that could affect short-term obligations. The company’s book value per share is reported at ₹6.93, which, when compared to the market price of ₹21.5, results in a price-to-book value (P/BV) ratio of 3.71x. While this indicates a premium valuation, it raises questions about sustainability given the company’s profitability struggles. Overall, the balance sheet shows that while the company has a solid asset base, its financial ratios highlight critical concerns regarding liquidity and profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Andrew Yule & Company Ltd indicates a strong promoter holding of 89.25%, reflecting significant control by the founding family. This concentrated ownership can instill confidence among investors regarding long-term strategic direction. However, foreign institutional investors (FIIs) have shown minimal interest, with holdings at 0.00%, which may highlight concerns about the company’s growth prospects. Domestic institutional investors (DIIs) represent 2.20% of the shareholding, while the public holds 8.55%, suggesting limited retail investor participation. The number of shareholders has increased to 47,115 as of September 2025, which could imply a growing interest in the stock despite the current performance challenges. The consistent promoter stake indicates a commitment to the company, but the lack of diversification in shareholding raises concerns about governance and responsiveness to market dynamics.
Outlook, Risks, and Final Insight
The outlook for Andrew Yule & Company Ltd appears challenging, primarily due to ongoing profitability issues and operational inefficiencies. The significant volatility in sales and negative operating margins poses substantial risks to sustainability. Key strengths include a solid promoter backing and effective management of working capital, as indicated by the negative cash conversion cycle. However, the risks associated with high leverage, low liquidity, and minimal institutional investor interest cannot be overlooked. Moving forward, the company must focus on enhancing operational efficiencies and stabilizing revenue streams to regain investor confidence. If successful in addressing these issues, Andrew Yule could see a turnaround, but failure to improve profitability may lead to further deterioration in market perception and financial health.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 357 Cr. | 165 | 270/150 | 123 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 42.1 Cr. | 28.1 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 142 Cr. | 158 | 185/126 | 14.1 | 223 | 0.95 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 123 Cr. | 398 | 639/350 | 13.2 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,850.47 Cr | 397.73 | 66.83 | 265.00 | 0.43% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.07 | 119.98 | 81.14 | 58.58 | 87.99 | 86.72 | 76.57 | 55.53 | 89.42 | 68.33 | 98.43 | 56.14 | 71.52 |
| Expenses | 94.13 | 114.18 | 97.55 | 79.39 | 100.16 | 108.03 | 111.71 | 67.28 | 79.34 | 88.00 | 140.66 | 83.80 | 76.13 |
| Operating Profit | 21.94 | 5.80 | -16.41 | -20.81 | -12.17 | -21.31 | -35.14 | -11.75 | 10.08 | -19.67 | -42.23 | -27.66 | -4.61 |
| OPM % | 18.90% | 4.83% | -20.22% | -35.52% | -13.83% | -24.57% | -45.89% | -21.16% | 11.27% | -28.79% | -42.90% | -49.27% | -6.45% |
| Other Income | 10.86 | 8.68 | 9.03 | 10.01 | 7.58 | 11.67 | 8.81 | 5.23 | 11.14 | 10.36 | 36.82 | 59.71 | 11.00 |
| Interest | 2.12 | 2.76 | 2.86 | 3.25 | 3.18 | 4.31 | 4.76 | 4.62 | 5.07 | 4.36 | -7.48 | 4.99 | 4.41 |
| Depreciation | 1.77 | 1.44 | 1.97 | 1.90 | 1.46 | 1.39 | 2.20 | 1.52 | 1.60 | 1.67 | 17.13 | 1.52 | 1.61 |
| Profit before tax | 28.91 | 10.28 | -12.21 | -15.95 | -9.23 | -15.34 | -33.29 | -12.66 | 14.55 | -15.34 | -15.06 | 25.54 | 0.37 |
| Tax % | 12.80% | 54.96% | -12.61% | -0.00% | -21.34% | -13.75% | -16.49% | -2.45% | 10.72% | -9.26% | -18.53% | 7.28% | 470.27% |
| Net Profit | 20.95 | 6.99 | -5.86 | -7.51 | -5.27 | -12.48 | -22.21 | -2.67 | 14.83 | -14.40 | -0.61 | 20.14 | -0.02 |
| EPS in Rs | 0.43 | 0.14 | -0.12 | -0.15 | -0.11 | -0.26 | -0.45 | -0.05 | 0.30 | -0.29 | -0.01 | 0.41 | -0.00 |
Last Updated: February 3, 2026, 5:46 am
Below is a detailed analysis of the quarterly data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 71.52 Cr.. The value appears strong and on an upward trend. It has increased from 56.14 Cr. (Jun 2025) to 71.52 Cr., marking an increase of 15.38 Cr..
- For Expenses, as of Sep 2025, the value is 76.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 83.80 Cr. (Jun 2025) to 76.13 Cr., marking a decrease of 7.67 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.61 Cr.. The value appears strong and on an upward trend. It has increased from -27.66 Cr. (Jun 2025) to -4.61 Cr., marking an increase of 23.05 Cr..
- For OPM %, as of Sep 2025, the value is -6.45%. The value appears strong and on an upward trend. It has increased from -49.27% (Jun 2025) to -6.45%, marking an increase of 42.82%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.71 Cr. (Jun 2025) to 11.00 Cr., marking a decrease of 48.71 Cr..
- For Interest, as of Sep 2025, the value is 4.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.99 Cr. (Jun 2025) to 4.41 Cr., marking a decrease of 0.58 Cr..
- For Depreciation, as of Sep 2025, the value is 1.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.52 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 25.54 Cr. (Jun 2025) to 0.37 Cr., marking a decrease of 25.17 Cr..
- For Tax %, as of Sep 2025, the value is 470.27%. The value appears to be increasing, which may not be favorable. It has increased from 7.28% (Jun 2025) to 470.27%, marking an increase of 462.99%.
- For Net Profit, as of Sep 2025, the value is -0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 20.14 Cr. (Jun 2025) to -0.02 Cr., marking a decrease of 20.16 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.00. The value appears to be declining and may need further review. It has decreased from 0.41 (Jun 2025) to 0.00, marking a decrease of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 382 | 372 | 385 | 421 | 367 | 312 | 299 | 330 | 414 | 374 | 310 | 311 | 294 |
| Expenses | 350 | 386 | 381 | 409 | 362 | 330 | 336 | 332 | 423 | 380 | 399 | 374 | 389 |
| Operating Profit | 32 | -14 | 4 | 12 | 6 | -19 | -37 | -2 | -8 | -6 | -89 | -64 | -94 |
| OPM % | 8% | -4% | 1% | 3% | 2% | -6% | -12% | -0% | -2% | -2% | -29% | -20% | -32% |
| Other Income | 11 | 46 | 22 | 42 | 28 | 40 | 29 | 31 | 34 | 32 | 38 | 64 | 118 |
| Interest | 12 | 11 | 10 | 9 | 7 | 6 | 8 | 8 | 8 | 10 | 16 | 22 | 6 |
| Depreciation | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 22 |
| Profit before tax | 26 | 14 | 10 | 38 | 20 | 7 | -23 | 14 | 11 | 9 | -74 | -29 | -4 |
| Tax % | 12% | 7% | 11% | 16% | 32% | 24% | -5% | -46% | 109% | 87% | -13% | -10% | |
| Net Profit | 35 | 46 | 21 | 45 | 22 | 6 | -22 | 35 | -5 | 13 | -47 | -3 | 5 |
| EPS in Rs | 1.08 | 1.38 | 0.63 | 0.93 | 0.46 | 0.11 | -0.44 | 0.72 | -0.11 | 0.26 | -0.97 | -0.06 | 0.11 |
| Dividend Payout % | 0% | 7% | 0% | 11% | 9% | 0% | 0% | 0% | 0% | 3% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.43% | -54.35% | 114.29% | -51.11% | -72.73% | -466.67% | 259.09% | -114.29% | 360.00% | -461.54% | 93.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.78% | 168.63% | -165.40% | -21.62% | -393.94% | 725.76% | -373.38% | 474.29% | -821.54% | 555.16% |
Andrew Yule & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -9% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | 8% |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -6% |
| Last Year: | -8% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:22 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 65 | 67 | 67 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 |
| Reserves | 239 | 278 | 299 | 238 | 257 | 253 | 245 | 281 | 276 | 287 | 242 | 241 | 264 |
| Borrowings | 94 | 98 | 88 | 41 | 28 | 53 | 81 | 70 | 67 | 100 | 114 | 105 | 120 |
| Other Liabilities | 178 | 189 | 187 | 212 | 187 | 187 | 179 | 187 | 197 | 257 | 257 | 308 | 273 |
| Total Liabilities | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
| Fixed Assets | 181 | 183 | 186 | 81 | 85 | 87 | 94 | 103 | 112 | 142 | 162 | 192 | 191 |
| CWIP | 6 | 5 | 1 | 18 | 37 | 59 | 77 | 75 | 82 | 94 | 88 | 61 | 63 |
| Investments | 97 | 131 | 143 | 169 | 179 | 179 | 202 | 203 | 197 | 201 | 219 | 244 | 240 |
| Other Assets | 292 | 313 | 311 | 321 | 270 | 265 | 228 | 255 | 247 | 305 | 242 | 256 | 261 |
| Total Assets | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
Below is a detailed analysis of the balance sheet data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 98.00 Cr..
- For Reserves, as of Sep 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 241.00 Cr. (Mar 2025) to 264.00 Cr., marking an increase of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 105.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 15.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing). It has decreased from 308.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 35.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 755.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2025) to 191.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2025) to 240.00 Cr., marking a decrease of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 261.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 755.00 Cr.. The value appears strong and on an upward trend. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (264.00 Cr.) exceed the Borrowings (120.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -112.00 | -84.00 | -29.00 | -22.00 | -72.00 | -118.00 | -72.00 | -75.00 | -106.00 | -203.00 | -169.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 107 | 103 | 103 | 79 | 79 | 62 | 70 | 70 | 115 | 118 | 146 |
| Inventory Days | 131 | 104 | 132 | 106 | 156 | 203 | 201 | 185 | 193 | 155 | 109 | 134 |
| Days Payable | 301 | 250 | 281 | 223 | 212 | 227 | 223 | 252 | 231 | 304 | 246 | 351 |
| Cash Conversion Cycle | -74 | -40 | -46 | -15 | 23 | 55 | 40 | 2 | 32 | -33 | -19 | -71 |
| Working Capital Days | -25 | -41 | -27 | 16 | 1 | -26 | -87 | -54 | -10 | -53 | -154 | -187 |
| ROCE % | 10% | 6% | 4% | 7% | 7% | 2% | -4% | 5% | 9% | 4% | -14% | -7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Diluted EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Cash EPS (Rs.) | -0.38 | -1.17 | 0.15 | 0.11 | 0.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Revenue From Operations / Share (Rs.) | 6.38 | 6.34 | 7.65 | 8.47 | 6.76 |
| PBDIT / Share (Rs.) | 0.00 | -1.04 | 0.51 | 0.98 | 0.60 |
| PBIT / Share (Rs.) | -0.13 | -1.18 | 0.38 | 0.85 | 0.46 |
| PBT / Share (Rs.) | -0.58 | -1.50 | 0.18 | 0.22 | 0.30 |
| Net Profit / Share (Rs.) | -0.52 | -1.31 | 0.02 | -0.01 | 0.41 |
| NP After MI And SOA / Share (Rs.) | -0.05 | -0.97 | 0.25 | -0.10 | 0.71 |
| PBDIT Margin (%) | 0.00 | -16.37 | 6.79 | 11.62 | 8.91 |
| PBIT Margin (%) | -2.11 | -18.62 | 5.07 | 10.06 | 6.89 |
| PBT Margin (%) | -9.14 | -23.62 | 2.39 | 2.67 | 4.44 |
| Net Profit Margin (%) | -8.19 | -20.73 | 0.31 | -0.23 | 6.18 |
| NP After MI And SOA Margin (%) | -0.91 | -15.32 | 3.38 | -1.28 | 10.63 |
| Return on Networth / Equity (%) | -0.83 | -13.99 | 3.28 | -1.42 | 9.27 |
| Return on Capital Employeed (%) | -1.69 | -14.42 | 4.18 | 9.57 | 5.42 |
| Return On Assets (%) | -0.37 | -6.68 | 1.70 | -0.83 | 5.52 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.31 | 0.33 | 0.25 | 0.17 | 0.18 |
| Asset Turnover Ratio (%) | 0.42 | 0.42 | 0.63 | 0.76 | 0.62 |
| Current Ratio (X) | 0.66 | 0.70 | 0.98 | 1.11 | 1.09 |
| Quick Ratio (X) | 0.55 | 0.59 | 0.80 | 0.86 | 0.87 |
| Inventory Turnover Ratio (X) | 8.38 | 2.36 | 2.57 | 1.99 | 1.88 |
| Interest Coverage Ratio (X) | 0.00 | -3.27 | 2.54 | 6.04 | 3.64 |
| Interest Coverage Ratio (Post Tax) (X) | -0.16 | -3.11 | 1.12 | 3.72 | 3.62 |
| Enterprise Value (Cr.) | 1325.93 | 1776.01 | 1039.44 | 1022.55 | 967.67 |
| EV / Net Operating Revenue (X) | 4.25 | 5.73 | 2.78 | 2.47 | 2.93 |
| EV / EBITDA (X) | -51194.25 | -35.00 | 40.90 | 21.23 | 32.85 |
| MarketCap / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| Price / BV (X) | 3.71 | 5.01 | 2.57 | 2.64 | 2.55 |
| Price / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| EarningsYield | 0.00 | -0.02 | 0.01 | -0.01 | 0.03 |
After reviewing the key financial ratios for Andrew Yule & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 3. It has increased from -1.17 (Mar 24) to -0.38, marking an increase of 0.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.34 (Mar 24) to 6.38, marking an increase of 0.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has increased from -1.04 (Mar 24) to 0.00, marking an increase of 1.04.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 0. It has increased from -1.18 (Mar 24) to -0.13, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 0. It has increased from -1.50 (Mar 24) to -0.58, marking an increase of 0.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 2. It has increased from -1.31 (Mar 24) to -0.52, marking an increase of 0.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.05, marking an increase of 0.92.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -16.37 (Mar 24) to 0.00, marking an increase of 16.37.
- For PBIT Margin (%), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 10. It has increased from -18.62 (Mar 24) to -2.11, marking an increase of 16.51.
- For PBT Margin (%), as of Mar 25, the value is -9.14. This value is below the healthy minimum of 10. It has increased from -23.62 (Mar 24) to -9.14, marking an increase of 14.48.
- For Net Profit Margin (%), as of Mar 25, the value is -8.19. This value is below the healthy minimum of 5. It has increased from -20.73 (Mar 24) to -8.19, marking an increase of 12.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 8. It has increased from -15.32 (Mar 24) to -0.91, marking an increase of 14.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.83. This value is below the healthy minimum of 15. It has increased from -13.99 (Mar 24) to -0.83, marking an increase of 13.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is -1.69. This value is below the healthy minimum of 10. It has increased from -14.42 (Mar 24) to -1.69, marking an increase of 12.73.
- For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has increased from -6.68 (Mar 24) to -0.37, marking an increase of 6.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.31, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. There is no change compared to the previous period (Mar 24) which recorded 0.42.
- For Current Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1.5. It has decreased from 0.70 (Mar 24) to 0.66, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.55, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 8. It has increased from 2.36 (Mar 24) to 8.38, marking an increase of 6.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -3.27 (Mar 24) to 0.00, marking an increase of 3.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 3. It has increased from -3.11 (Mar 24) to -0.16, marking an increase of 2.95.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,325.93. It has decreased from 1,776.01 (Mar 24) to 1,325.93, marking a decrease of 450.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.25. This value exceeds the healthy maximum of 3. It has decreased from 5.73 (Mar 24) to 4.25, marking a decrease of 1.48.
- For EV / EBITDA (X), as of Mar 25, the value is -51,194.25. This value is below the healthy minimum of 5. It has decreased from -35.00 (Mar 24) to -51,194.25, marking a decrease of 51,159.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 5.01 (Mar 24) to 3.71, marking a decrease of 1.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.02 (Mar 24) to 0.00, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Andrew Yule & Company Ltd:
- Net Profit Margin: -8.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -1.69% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.83% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.16
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 228 (Industry average Stock P/E: 66.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.31
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Yule House, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ananta Mohan Singh | Chairman & Managing Director |
| Mr. Sanjay Verma | Director - Finance |
| Mr. Sunder Pal Singh | Ind. Non-Executive Director |
| Ms. Swapna Tripathy | Ind. Non-Executive Director |
| Mr. Vijay Mittal | Nominee Director |
| Mr. Brajesh Kumar Srivastava | Nominee Director |
FAQ
What is the intrinsic value of Andrew Yule & Company Ltd?
Andrew Yule & Company Ltd's intrinsic value (as of 10 February 2026) is ₹113.88 which is 406.13% higher the current market price of ₹22.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,102 Cr. market cap, FY2025-2026 high/low of ₹37.6/20.2, reserves of ₹264 Cr, and liabilities of ₹755 Cr.
What is the Market Cap of Andrew Yule & Company Ltd?
The Market Cap of Andrew Yule & Company Ltd is 1,102 Cr..
What is the current Stock Price of Andrew Yule & Company Ltd as on 10 February 2026?
The current stock price of Andrew Yule & Company Ltd as on 10 February 2026 is ₹22.5.
What is the High / Low of Andrew Yule & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Andrew Yule & Company Ltd stocks is ₹37.6/20.2.
What is the Stock P/E of Andrew Yule & Company Ltd?
The Stock P/E of Andrew Yule & Company Ltd is 228.
What is the Book Value of Andrew Yule & Company Ltd?
The Book Value of Andrew Yule & Company Ltd is 7.39.
What is the Dividend Yield of Andrew Yule & Company Ltd?
The Dividend Yield of Andrew Yule & Company Ltd is 0.00 %.
What is the ROCE of Andrew Yule & Company Ltd?
The ROCE of Andrew Yule & Company Ltd is 6.83 %.
What is the ROE of Andrew Yule & Company Ltd?
The ROE of Andrew Yule & Company Ltd is 7.96 %.
What is the Face Value of Andrew Yule & Company Ltd?
The Face Value of Andrew Yule & Company Ltd is 2.00.